A multicenter prospective cohort trial using of One Step Nuclei Acid Amplification Method in sentinel lymph node biopsy for early breast cancer patients

A multicenter prospective cohort trial using of One Step Nuclei Acid Amplification Method in sentinel lymph node biopsy for early breast cancer patients - A multicenter prospective cohort trial using of One Step Nuclei Acid Amplification Method in sentinel lymph node biopsy for early breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012623

Enrollment

4500

Registered

2014-01-06

Start date

2014-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cT1-2N0M0 breast cancer patients

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) invasive breast cancer diagnosed by core needle biopsy or fine needle aspiration cytology 2) clinical T1-2N0M0 3) patient who had breast conserving surgery and mastectomy with postoperative irradiation and adjuvant therapy 4) We obtained informed consent from all patients who participated in this study.

Exclusion criteria

Exclusion criteria: 1) patients who had neoaduvant therapy 2) We did not obtain informed consent from all patients who participated in this study.

Design outcomes

Primary

Measure	Time frame
Disease free survival	—

Secondary

Measure	Time frame
Overall survival, local recurrence rate, postoperative complication, non-SLN metastasis rate in patient with ALND	—

Countries

Japan

Contacts

Public ContactDaisuke Yotsumoto

Sagara Hospital, Social Medical Corporation Hakuaikai Department of Breast Oncology

yotumoto@sagara.or.jp099-224-1800

Outcome results